17 Jun 2013
A study from the Netherlands presented at ENDO 2013 assesses metabolism, growth and bone health in 127 adolescent patients with gender dysphoria who received gonadotropin-releasing hormone analogs to block puberty, and later opted to receive cross-sex hormones.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024